Neuroendocrine neoplasia of the gastroenteropancreatic system. Pathology and classification;Neuroendokrine Neoplasien des gastroenteropankreatischen Systems: Pathologie und Klassifikation

Onkologe

Volumn 17, Issue 7, 2011, Pages 572-582

  Anlauf, M ^a   Gerlach, P ^a   Raffel, A ^a   Schott, M ^a   Baum, R ^b   Pavel, M ^c   Kloppel G ^d  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b ZENTRALKLINIK BAD BERKA   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Classification; Grading; Molecular imaging; Neuroendocrine tumor; Proliferation

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER THERAPY; INTESTINE TUMOR; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRACTICE GUIDELINE; PROGNOSIS; STOMACH TUMOR;

EID: 80052564935     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-011-2052-6     Document Type: Article

References (31)

1. Adams S, Baum RP, Hertel A et al (1998) Metabolic(PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen. Nucl Med Commun 19:641-647. (Pubitemid 28368315)
2. Baum RP, Prasad V (2008) PET and PET/CT. Imaging of Neuroendocrine Tumors. In: Wahl RL (Hrsg) Principles and Practice of PET and PET/CT. 2. Aufl, Wolters Kluwer/Lippincott Williams & Wilkins, S 411-437.
3. Baum RP, Prasad, V, Hommann M, Hörsch D (2008) Receptor PET/CT imaging of neuroendocrine tumors. Recent Results Cancer Res 170 225-242.
4. Ahlman H, Nilsson O, McNicol AM et al (2008) Frascati Consensus Conference participants. Poor-ly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin. Neuroendocrinology 87(1):40-46. (Pubitemid 350308293)
5. Anlauf M, Garbrecht N, Henopp T et al (2006) Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroent-erol 12(34):5440-5446. (Pubitemid 44501800)
6. Anlauf M, Perren A, Klöppel G (2007) Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance. Pathobiology 74(5):279-284. (Pubitemid 47450573)
7. Anlauf M, Schlenger R, Perren A et al (2006) Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol 30:560-574. (Pubitemid 44265008)
8. Eissele R, Anlauf M, Schäfer MKH et al (1999) Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. Digestion 60:428-439. (Pubitemid 29401771)
9. Falconi M, Plockinger U, Kwekkeboom DJ et al (2006) Frascati Consensus Conference; European Neuroendocrine Tumor Society. Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma. Neuroendocrinology 84:196-211. (Pubitemid 46361054)
10. Garbrecht N, Anlauf M, Schmitt A et al (2008) Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syn-dromes, and functional activity. Endocr Relat Cancer 15(1):229-241. (Pubitemid 351449742)
11. Garcia-Carbonero R, Capdevila J, Crespo-Herrero G et al (2010) Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol 21(9):1794-1803.
12. Heitz PU, Komminoth P, Perren A et al (2004) Pancreatic endocrine tumours: introduction. In: RA DeLellis, RV Lloyd, PU Heitz, C Eng (Hrsg) Pathology and genetics: tumours of endocrine organs. WHO classification of tumors. IARC Press, Lyon, S 177-182.
13. Henopp T, Anlauf M, Schmitt A et al (2009) Glucagon cell adenomatosis: a newly recognised disease of the endocrine pancreas. J Clin Endocrinol Metab 94(1):213-217.
14. Klöppel G, Anlauf M (2005) Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 19:507-517. (Pubitemid 41447715)
15. Klöppel G, Anlauf M (2007) Gastrinoma - morphological aspects. Wien Klin Wochenschr 119:579-584.
16. Klöppel G, Couvelard A, Perren A et al (2009) Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 90:162-166.
17. Klöppel G, Rindi G, Anlauf M et al (2007) Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 451(Suppl 1):S9-27.
18. Klöppel G, Rindi G, Perren A et al (2010) The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 456:595-597.
19. Miederer M, Seidl S, Buck A et al (2009) Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 36(1):48-52.
20. Nilsson O, Van Cutsem E, Delle Fave G et al (2006) Frascati Consensus Conference; European Neuroendocrine Tumor Society. Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic). Neuroendocrinology 84(3):212-215. (Pubitemid 46361055)
21. O'Toole D, Salazar R, Falconi M et al (2006) Frascati Consensus Conference; European Neuroendocrine Tumor Society. Rare Functioning Pancreatic Endocrine Tumors. Neuroendocrinology 84(3):189-195. (Pubitemid 46361053)
22. Pape UF, Jann H, Müller-Nordhorn J et al (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 15;113(2):256-265.
23. Ploeckinger U, Kloeppel G, Wiedenmann B, Lohmann R (2009) Representatives of 21 German NET Centers. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology 90(4):349-363.
24. Rindi G, Arnold R, Bosman FT et al (2010) Nomenclature and classification of Neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (Hrsg). WHO classification of tumors of the digestive system. IARC, Lyon, S 13-14.
25. Rindi G, Klöppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395-401. (Pubitemid 44451313)
26. Rindi G, Klöppel G, Couvelard A et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451:757-762. (Pubitemid 47497934)
27. Scarpa A, Mantovani W, Capelli P et al (2010) Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 23(6):824-833.
28. Schmitt AM, Riniker F, Anlauf M et al (2008) Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Am J Surg Pathol 32:420-425. (Pubitemid 351398934)
29. th edition. Wiley & Sons.
30. Solcia E, Klöppel G, Sobin LH (2000) In collaboration with 9 pathologists from 4 countries. Histological typing of endocrine tumours. 2. Aufl. WHO international histological classification of tumours. Springer, Berlin.
31. Vinik AI, Woltering EA, Warner RR et al (2010) North American Neuroendocrine Tumor Society (NANETS). NANETS consensus guidelines for the diagnosis of neuroendocrine tumors. Pancreas 39:713-734.